![Guillaume Baril](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Guillaume Baril
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Phixen SAS
![]() Phixen SAS Financial ConglomeratesFinance Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million.
6
| Subsidiary | Financial Conglomerates | 6 |
Phinex SAS
![]() Phinex SAS Financial ConglomeratesFinance Phinex SAS operates as a holding company. The company is headquartered in Fontenay-sous-Bois, France.
4
| Private Company | Financial Conglomerates | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Guillaume Baril via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
EUROGERM SA | Food: Specialty/Candy | Director/Board Member | |
Oddo BHF Asset Management SAS
![]() Oddo BHF Asset Management SAS Investment ManagersFinance Oddo BHF Asset Management SAS (Oddo BHF AM) is an investment adviser founded in 1978 and is headquartered in Paris, France. The firm is a subsidiary of Oddo BHF SCA. Oddo BHF AM provides asset management and financial advisory services to domestic and international private clients, companies, institutional investors, and IFAs. | Investment Managers | Private Equity Investor | |
CEGEDIM | Packaged Software | Director/Board Member | |
Pierre Fabre SA
![]() Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pierre Fabre Médicament SAS
![]() Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Cathay Capital Private Equity SAS
![]() Cathay Capital Private Equity SAS Investment ManagersFinance Cathay Capital Private Equity SAS (Cathay Capital PE) is a private equity firm founded in 2007 by Mingpo Cai and Edouard Moinet. The firm is headquartered in Paris, France. | Investment Managers | Founder Private Equity Investor | |
Bristol-Myers Squibb SARL
![]() Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Medical Distributors | Corporate Officer/Principal | |
Cenexi SAS
![]() Cenexi SAS Pharmaceuticals: MajorHealth Technology Cenexi SASU specializes in the contract manufacturing of pharmaceuticals for humans and veterinary markets. It also manufactures solid forms (tablets and capsules), syrups, suppositories and parental ampoules for the world market. The company was founded in 2004 and is headquartered in Fontenay-sous-Bois, France. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Executive Officer | |
Seaowl France SASU
![]() Seaowl France SASU Marine ShippingTransportation Seaowl France SASU specializes in the maritime and coastal freight transport. The company was founded in 2008 and is headquartered in Levallois-Perret, France. | Marine Shipping | Director/Board Member | |
QUANTUM GENOMICS | Pharmaceuticals: Major | Director/Board Member | |
SOPHiA GENETICS SAS
![]() SOPHiA GENETICS SAS Data Processing ServicesTechnology Services Part of SOPHiA GENETICS SA, SOPHiA GENETICS SAS provides data processing, hosting and related activity services. The company is based in Montpellier, France. | Data Processing Services | Director/Board Member | |
Pierre Fabre Ltd.
![]() Pierre Fabre Ltd. Household/Personal CareConsumer Non-Durables Part of Pierre Fabre Participations SAS, Pierre Fabre Ltd. is a British company that develops innovative solutions for the well-being of everyone, from health to beauty. The company is based in London, UK. The company's flagship products include purifying mist, fortifying shampoo, dry shampoo, and anti-dandruff shampoo for hair care, as well as treatments for chronic diseases such as heavy legs, urinary disorders, allergies, type 2 diabetes, and anemia. The company also offers a range of iconic brands under the Pierre Fabre brand, including Eau Thermale Avène, Ducray, Dexeryl, Eludril, Elgydium, and Naturactive. The company has a best practices guide for relations with patient associations to ensure responsible and sound decision-making. | Household/Personal Care | Director/Board Member | |
BIODEXA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
Delpharm Industrie SAS
![]() Delpharm Industrie SAS BiotechnologyHealth Technology Delpharm Industrie SAS engages in the manufacture and development of CDMO drugs. It produces dosage forms, non-sterile and sterile liquids, solids, semi-solids and biotech products. The company was founded in 1988 and is headquartered in Boulogne-Billancourt, France. | Biotechnology | Chief Executive Officer | |
Cenexi - Laboratoires Thissen SA
![]() Cenexi - Laboratoires Thissen SA Pharmaceuticals: MajorHealth Technology Part of Phinex SAS, Cenexi - Laboratoires Thissen SA is a development and subcontracting Belgian company specializing in sterile and organic products. Founded in 2012, the company is based in Braine l'Alleud, Belgium. Cenexi partners with pharmaceutical laboratories and biotechs to develop and manufacture innovative drugs. The company's expert entity, Cenexi Services, provides formulation, analytical and galleic developments, industrial transfer, and regulatory support. The company pursues a dynamic recruitment policy, hiring around 125 positions in France and 50 in Belgium every year. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Groupe GlaxoSmithKline SAS
![]() Groupe GlaxoSmithKline SAS Financial ConglomeratesFinance Part of GSK Plc, Groupe GlaxoSmithKline SAS is an investment holding French company. The company is based in Rueil-Malmaison, France. | Financial Conglomerates | Corporate Officer/Principal | |
Cenexi Hsc SAS
![]() Cenexi Hsc SAS Pharmaceuticals: MajorHealth Technology Cenexi HSC SAS is a French company founded in 2004 that specializes in the development and manufacturing of sterile and biological products. The company is based in Fontenay-sous-Bois, France. The company's services include formulation, analytical and galenic development, industrial transfer, and regulatory support. | Pharmaceuticals: Major | Chairman | |
Cenexi Services SAS
![]() Cenexi Services SAS Pharmaceuticals: MajorHealth Technology Part of Phinex SAS, Cenexi Services SAS is a French company that provides contract development and manufacturing services for pharmaceutical companies. The company is based in Fontenay-sous-Bois, France. The company was founded in 2010. Alain Kirchmeyer has been the CEO of the company since 2024. | Pharmaceuticals: Major | Chief Executive Officer | |
Cenexi 2 SASU
![]() Cenexi 2 SASU Pharmaceuticals: MajorHealth Technology Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Cenexi 2 SASU is a contract manufacturing and development organization of pharmaceutical products. The company is based in Fontenay-sous-Bois, France. The French company was founded in 2016. The CEO is Christophe Durand. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
Frankrijk | 18 |
Verenigd Koninkrijk | 3 |
België | 2 |
Sectoraal
Health Technology | 12 |
Finance | 4 |
Consumer Non-Durables | 3 |
Technology Services | 3 |
Distribution Services | 2 |
Operationeel
Director/Board Member | 18 |
Chief Executive Officer | 5 |
Corporate Officer/Principal | 5 |
Chairman | 4 |
Private Equity Investor | 3 |
Sterkste connecties
Insiders | |
---|---|
Frédéric Duchesne | 13 |
Christophe Durand | 6 |
Edouard Moinet | 5 |
Benoit Seringe | 4 |
Philippe Mougin | 3 |
Alain Kirchmeyer | 3 |
Ming Cai | 1 |
- Beurs
- Insiders
- Guillaume Baril
- Bedrijfsconnecties